Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$570.66Cboe Real-Time Last Sale as of 1:43PM ET 9/29/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change-1.26(0.22%)
Bid (Size)$570.17 (27)
Ask (Size)$571.04 (11)
Day Low / High$567.92 - 575.62
Volume191.1 K

Consensus Q3, 2020, 2021 Estimates for Regeneron Pharmaceuticals Raised

11:50AM ET 8/07/2020 MT Newswires
Q3, 2020, and 2021`s consensus forecasts for Regeneron Pharmaceuticals Inc (NASDAQ:REGN, Recent Price: 621.21) have been raised. The Q3 earnings estimate has been increased to $6.83 per share, up from the previous consensus forecast of $5.98 per share, as have the full year estimates for 2020 and 2021. The 2020 estimate has been increased to $27.89 per share from the previous consensus of $27.48 per share and the full year 2021 estimate has been scaled up from $32.78 per share to $33.16 per share. At the present time there are 20 estimates used to calculate the Q3 forecast and 25 published estimates included in the full year forecasts for both 2020 and 2021.